| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/29/2007 | CN101024026A Medicine for treating parotitis |
| 08/29/2007 | CN101024024A Bacteria-resistant poison-eliminating animal's medicine |
| 08/29/2007 | CN101024018A Chinese medicine for treating herps zoster |
| 08/29/2007 | CN101024013A Medicine for treating tuberculosis |
| 08/29/2007 | CN101024009A Compounded zhidi total extract and its preparation and use |
| 08/29/2007 | CN101023997A Anti-fowl-plague Chinese medicine and preparing method |
| 08/29/2007 | CN101023996A Chinese medicine for treating exogenous epidemic disease and anemopyretic cold |
| 08/29/2007 | CN101023990A Chinese readymade medicine for treating exogenous disease |
| 08/29/2007 | CN101023989A Chinese medicine for treating virus herps and preparing method |
| 08/29/2007 | CN101023985A Medicine for treating tinea mannum and tinea pedis and preparing method thereof |
| 08/29/2007 | CN101023976A Medicine composition with anti-virus function and its preparing method |
| 08/29/2007 | CN101023974A Preparing method for honeysuckle paste |
| 08/29/2007 | CN101023972A Use of phenolic acids effective part in dandelion for treating stomatocace |
| 08/29/2007 | CN101023960A Preparation of anti-virus, anti-tumor medicine of nano methanaminium containing earopium |
| 08/29/2007 | CN101023957A Single-chain deoxidized oligonucleotide containing CPG of resisting infuenza virus |
| 08/29/2007 | CN101023955A Medicine composition and use |
| 08/29/2007 | CN101023947A Methods and compositions for bactericide, bacteriostatic and anti-inflammation |
| 08/29/2007 | CN101023945A Use of non-periphery substituted phthalocyaniu metal complex |
| 08/29/2007 | CN101023769A Aloe air-conditioning tea |
| 08/29/2007 | CN100334228C Cimeric immunomodulatory compounds and methods of using the same |
| 08/29/2007 | CN100334112C Interfusion protein of human interleukin 15 and Fe |
| 08/29/2007 | CN100334107C Ligands |
| 08/29/2007 | CN100334083C Piperidine derivatives as CCR5 inhibitors |
| 08/29/2007 | CN100333794C Adjuvanted genetic vaccines |
| 08/29/2007 | CN100333793C Diploid-cell rabies vaccine and purified rabies vaccine, freeze-drying preparation and water injection thereof |
| 08/29/2007 | CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine |
| 08/29/2007 | CN100333790C The pharmaceutical applications for combination of drugs with interleukin-2 |
| 08/29/2007 | CN100333789C Gel gent of Chiense forest frog bactericidal peptide and its preparation process |
| 08/29/2007 | CN100333787C YG and YGG used as maintenance and improvement of immunoreaction |
| 08/29/2007 | CN100333769C Chinese herbal granule for treating viral myocarditis and its preparing process |
| 08/29/2007 | CN100333764C Pill for treating liver disease |
| 08/29/2007 | CN100333756C Chinese medicinal preparation for hepatitis and its preparing method |
| 08/29/2007 | CN100333740C Tincture for trenting fungus dermatosis |
| 08/29/2007 | CN100333739C External sterilizing Mongolian medicine lotion for skin and external genital organs |
| 08/29/2007 | CN100333724C Lomefloxacin eye gel |
| 08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
| 08/28/2007 | US7262293 precipitating from acidic aqueous solutions dropped into an aqueous or anhydrous solvents, then freeze drying to form amorphous salts having storage stability; monocyclic beta-lactam antibiotics |
| 08/28/2007 | US7262286 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262271 Immunogens as well as antibodies |
| 08/28/2007 | US7262268 Acylating a destryptophan compound to obtain an ornithin amino protected compound, removing the ornithine protecting group; antibiotic daptomycin stereoisomeric compounds |
| 08/28/2007 | US7262212 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 08/28/2007 | US7262201 Quinazoline derivatives |
| 08/28/2007 | US7262177 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
| 08/28/2007 | US7262172 Bactericides; therapy for infections |
| 08/28/2007 | US7262014 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 08/28/2007 | US7261897 Fusion proteins of mycobacterium tuberculosis |
| 08/28/2007 | CA2504078C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 08/28/2007 | CA2405072C Gel compositions containing metronidazole |
| 08/28/2007 | CA2367755C Dimeric compounds and their use as inhibitors of neuraminidase |
| 08/28/2007 | CA2247232C Antimicrobial composition |
| 08/28/2007 | CA2218619C Antibacterial-wound healing compositions and methods for preparing and using same |
| 08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 08/28/2007 | CA2184727C Proteasome regulation of nf-kb activity |
| 08/28/2007 | CA2160243C 36-derivatives of rifamycins and their use as antimicrobial agents |
| 08/28/2007 | CA2123355C Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci |
| 08/24/2007 | CA2579517A1 Ionized water and method of producing same |
| 08/24/2007 | CA2568981A1 Integrase-derived hiv-inhibiting agents |
| 08/23/2007 | WO2007095223A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 08/23/2007 | WO2007095218A1 Intravenous antiviral treatments |
| 08/23/2007 | WO2007095043A2 Pharmaceutical formulations |
| 08/23/2007 | WO2007094462A1 Non-human animal having modified genome or offspring thereof |
| 08/23/2007 | WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody |
| 08/23/2007 | WO2007094137A1 Method of inducing cytotoxic t-cell, cytotoxic t-cell inducer and, produced therewith, pharmaceutical composition and vaccine |
| 08/23/2007 | WO2007093963A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 08/23/2007 | WO2007093904A1 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 08/23/2007 | WO2007093788A1 Use of antimicrobial compositions and novel methods for the delivery of such compostions |
| 08/23/2007 | WO2007093635A2 Proteasom or ups inhibitor for treating infections with influenza viruses |
| 08/23/2007 | WO2007093557A1 Sulfonamide derivatives for the treatment of bacterial infections |
| 08/23/2007 | WO2007093541A1 Heterocyclic antiviral compounds |
| 08/23/2007 | WO2007093520A1 Hetero-bycyclic antiviral compounds |
| 08/23/2007 | WO2007093515A1 Heterocyclic antiviral compounds |
| 08/23/2007 | WO2007093134A1 Aids vaccine based on replicative vaccinia virus vector |
| 08/23/2007 | WO2007079010A3 Carbonates of fenicol antibiotics |
| 08/23/2007 | WO2007074170A3 Compositions and methods for the treatment and prevention of disease |
| 08/23/2007 | WO2007058894A3 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 08/23/2007 | WO2007044695A3 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 08/23/2007 | WO2007007352A3 A vaccine for staphylococcal infections |
| 08/23/2007 | WO2006120568A3 Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone |
| 08/23/2007 | WO2006120567A3 Pharmaceutical composition comprising an anti-bacterial agent and an active ingredient selected from carveol, thymol, eugenol, borneol and carvacrol |
| 08/23/2007 | WO2006120565A3 Pharmaceutical combination comprising an antifungal agent and an active substance selected from carveol, eugenol, thymol, borneol, carvacrol and alpha- and beta-ionones |
| 08/23/2007 | WO2006067122A3 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 08/23/2007 | WO2005089738A3 Use and administration of bacterial efflux pump inhibitors |
| 08/23/2007 | US20070197656 reducing pro-inflammatory response in diseased cell of respiratory tract by contacting cell with an agent that increases ceramide levels in cell thereby reducing pro-inflammatory response in cell, wherein agent is fenretinide and diseased cell is representative of disease state of cystic fibrosis |
| 08/23/2007 | US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 08/23/2007 | US20070197602 Combined pharmaceutical composition |
| 08/23/2007 | US20070197533 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197501 Use Of Chemotherapeutic Agents |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197462 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus (EBV) or Kaposi's sarcoma-associated herpes (KHSV) |
| 08/23/2007 | US20070197434 Theurapeutic or prophyiactic agent for arthritis |
| 08/23/2007 | US20070197432 fusion protein comprising an amino acid sequence coupled to a single carrier keyhole limpet hemocyanin (KLH) protein and the bovine serum albumin (BSA) protein; vaccines; veterinary medicine |
| 08/23/2007 | US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 08/23/2007 | US20070196931 selectively kill Fusobacterium varium cells, or neutralize the toxin produced by Fusobacterium varium cells; differential diagnosis between ulcerative colitis and inflammatory bowel disease |
| 08/23/2007 | US20070196478 Antiviral compositions |
| 08/23/2007 | US20070196460 External preparation for treating skin or mucosal injury caused by viral infection |
| 08/23/2007 | US20070196417 Therapeutic polyanhydride compounds for drug delivery |
| 08/23/2007 | US20070196391 Mucosal boosting following parenteral priming |
| 08/23/2007 | US20070196390 Equine herpesvirus vaccine |